This study was performed to determine the effects of the angiotensinconverting enzyme inhibitor alacepril on hemodynamic variables and betaadrenoceptor number in rabbits with heart failure induced by aortic regurgitation. Aortic regurgitation was induced by perforation of the aortic valve in 12 rabbits. Sixty mg/kg of alacepril was administered by gastric tube for 7 days after manifestation of aortic regurgitation to 6 rabbits (group AR+A). The other 6 rabbits with aortic regurgitation were administered vehicle in the same fashion (group AR+C). Seven rabbits underwent sham operation (group S). One week after induction of aortic regurgitation left ventricular end-diastolic pressure was higher and cardiac output was lower in AR+C than in S. Enddiastolic and end-systolic left ventricular diameter were larger and left ventricular weight was also higher in AR+C than in S. For each of these parameters, the opposite findings were obtained from a comparison of AR+A and S. Myocardial beta-adrenoceptor density and norepinephrine content were reduced in AR+C, but were restored in AR+A. These findings indicate that alacepril has beneficial effects on ventricular remodeling and function, and on sympatho-neuronal regulation in the volume-overloaded myocardium. (Jpn Heart J 36: 91-100, 1995) Key words: aortic regurgitation heart failure angiotensin-converting enzyme inhibitor beta-adrenoceptor catecholamine T HE renin-angiotensin system is activated in patients with heart failure, and protects againt poor organ perfusion in the presence of low cardiac output.
Jpn Heart J January 1995 vanced heart failure. Angiotensin-converting enzyme inhibitors have been reported to have beneficial effects in patients with heart failure, including improvement of exercise capacity1,2) and prolongation of survival.3,4) Their effects are clinically superior to those of other vasodilating agents even when the hemodynamic status is comparable. 5, 6) In addition, the findings of the CONSENSUS study have shown that they are particularly useful for patients with severe congestive heart failure in whom neurohumoral activation has occurred.7) Angiotensinconverting enzyme inhibitors interact with the sympathetic nervous system to produce a variety of effects, including inhibition of norepinephrine release from the nerve terminal8) and baroreceptor sensitization,9) as well as direct elimination of excessive vasoconstriction.
We previously reported that myocardial beta-adrenoceptors were downregulated and myocardial catecholamines were depleted in rabbits with left ventricular failure following the induction of aortic regurgitation (AR).10) The angiotensin-converting enzyme inhibitor alacepril is metabolized in vivo to captopril and desacetylalacepril. It has an inhibitory effect on sympathetic vasoconstriction together with inhibition of the angiotensin-converting enzyme.11) The present study was designed to determine the effect of alacepril on hemodynamic variables and myocardial beta-adrenoceptors and catecholamines in volume-overloaded myocardium in rabbits.
METHODS AND MATERIALS
Induction of AR: AR was induced as previously described.12,13) Twelve female Japanese white rabbits were anesthetized with a 0.22mg/kg intravenous injection of chloral hydrate. The right carotid artery was isolated from the surrounding tissue. Aortic root pressure was measured with a 5F micromanometer-tipped catheter introduced through the carotid artery. The metal catheter was introduced from the right carotid artery, and advanced to the aortic root, where the motion of the aortic valve could be detected through the catheter. The metal catheter was pushed toward the left ventricle, and the aortic valve was perforated. Successful induction of AR was confirmed by the appearance of a diastolic murmur. Aortic pressure was measured again to assess the severity of AR.14) The right carotid artery was ligated, and the surgical incision closed. Antibiotics were injected post-surgically. Sham operation was performed in 7 other rabbits, in which the right carotid artery was ligated, but AR was not induced. Drug administration:
Alacepril was dissolved in 0.5% tragacanth solution as previously described.15) Sixty mg/kg of alacepril was administered once a day via a gastric tube for 1 week to 6 rabbits with AR (group AR+A). Tragacanth solution (0.5%) was administered in the same fashion as a vehicle to the remain- Hemodynamic data were recorded by a thermal array recorder (Nihon-Kohden Inc.) at 200mm/sec paper speed. Total forward stroke volume (TSV) and regurgitant volume (RV) were calculated from digitization of the positive and negative components of aortic flow using the MYPAD-A3 Logitec DIGITIZER (MODEL K-510). Stroke volume was calculated by subtraction of RV from TSV, and regurgitant fraction (RF) was calculated as follows: Upper panel shows maximal binding sites of beta-adrenoceptor (Bmax). Bmax was lower in AR+C than in S, but was higher in AR+A than in AR+C. As shown in the lower panel, dissociation constant (Kd) was higher in AR+A than in AR+C. *=p<0.05 compared with S; **=p<0.01 compared with S; ++=p<0.01 compared with AR+C. adrenoceptor number was reduced in rabbits with pressure and volume overload. In contrast, Yamazaki et al22) reported that numbers of myocardial betaadrenoceptors were increased in rats with AR. Florenzano et al23) reported that left ventricular contractility was increased following induction of AR in chronically instrumented conscious dogs. However, AR induced in our study was severe enough to explain this discrepancy in findings. AR can if severe enough, result in left ventricular failure in animal models. Mechanisms of improved hemodynamics and beta-adrenoceptors: Alacepril is an angiotensin-converting enzyme inhibitor, the effects of which are mediated by a metabolite, captopril. Desacetylalacepril, another metabolite of alacepril,24) has been found to attenuate the vasoconstrictive response to norepinephrine.25) Alacepril therefore exhibits both potent sympatho-inhibitory activity and inhibition of angiotensin-converting enzyme. Three explanations are possible for the improved hemodynamics and beta-adrenoceptors we observed: 1)direct vasodilation; 2)effects on sympatho-neuronal regulation; and 3)prevention of left ventricular remodeling. It is possible that alacepril dilated arteriolar resistance vessels resulting in a decrease in regurgitant volume. However, no significant difference was found between treated and nontreated rabbits in regurgitant fraction in our study. Gay26) reported that the pressure-volume curve shifted to the left in captopril-treated AR rats. He found no decrease in regurgitant volume, and presented no findings concerning sympatho-neuronal regulation. Clinical trials in patients with heart failure have shown that angiotensin-converting enzyme inhibitors increase survival more than other vasodilating agents.5,6) These agents are especially useful in the treatment of patients with severe congestive heart failure in whom neurohumoral activation has occurred.7) This emerging evidence suggests that other undefined mechanisms such as attenuation of sympatho-neuronal activities or prevention of ventricular remodeling are possible. Animal studies have shown that angiotensin-converting enzyme inhibitors induce up-regulation or enhanced beta-adrenergic responsiveness in intact or failing myocardium.27,28) A recent study29) demonstrated that the angiotensin-converting enzyme inhibitor lisinopril increased myocardial beta-adrenoceptor density in the failing human heart, although the hemodynamic changes induced by lisinopril were insignificant. Augmentation of sympatho-neuronal transmission occurred after induction of AR, resulting in down-regulation of betaadrenoceptors and depletion of catecholamines.10,20) It is possible that alacepril directly eliminated excessive activation of sympatho-neuronal transmission after induction of AR and protected the myocardium from excessive exposure to catecholamines. On the other hand, angiotensin-converting enzyme inhibitors have been shown to prevent ventricular remodeling in experimental myocardial infarction.30,31) Favorable effects of these drugs have also been obtained in clinical AR were not attributable to differences in severity of AR , since the decrease in aortic diastolic pressure after induction of AR , which is predictive of subsequent left ventricular overload,14) was similar in the two groups . Aortic diastolic pressure and regurgitant fraction were also similar for the two groups 1 week after induction of AR. We did not, however, determine the sequential changes which occurred in these variables during the week after induction of AR . Thus there was no difference in severity of volume overloading between the two groups . Favorable findings for the treated group appear to be caused by the effects of alacepril itself.
